European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer-Reference-Cited by-同舟云学术

European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer

Published:2008-09 Issue:13 Volume:44 Page:1807-1819
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lordick Florian,Ruers Theo,Aust Daniela E.,Collette Laurence,Downey Robert J,Hajjam Mostafa El,Flamen Patrick,Haustermans Karen,Ilson David,Julié Catherine,Krause Bernd Joachim,Newiger Hartwig,Ott Katja,Roth Arnaud,Cutsem Eric Van,Weber Wolfgang A.,Lutz Manfred P.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Medical Research Council Oesophageal Cancer Working Party, Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial, Lancet 359(2002) 1727–1733.

2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;New Engl J Med,2006

3. Survival benefi ts from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis;Gebski;Lancet Oncol,2007

4. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates;Folprecht;Ann Oncol,2005

5. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study;BMC Cancer;2018-05-09

2. Chances, risks and limitations of neoadjuvant therapy in surgical oncology;Innovative Surgical Sciences;2016-09-01

3. The Role of PET and PET-CT Scanning in Assessing Response to Neoadjuvant Therapy in Esophageal Carcinoma;Deutsches Ärzteblatt international;2015-08-17

4. The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy;European Journal of Nuclear Medicine and Molecular Imaging;2015-02-17

5. Unmet needs and challenges in gastric cancer: The way forward;Cancer Treatment Reviews;2014-07